• No results found

[PDF] Top 20 Amyotrophic Lateral SclerosisEthical Challenges

Has 10000 "Amyotrophic Lateral SclerosisEthical Challenges" found on our website. Below are the top 20 most common "Amyotrophic Lateral SclerosisEthical Challenges".

Amyotrophic Lateral SclerosisEthical Challenges

Amyotrophic Lateral SclerosisEthical Challenges

... T he diagnosis of an incurable disease causing progressive disability unaf- fected by life-prolonging measures gives rise to many ethical challenges. The core elements of medical ethics can be applied to support ... See full document

6

The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis

The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis

... Nevertheless, there are many remaining challenges. New techniques need to be harnessed and integrated into clinical research and practice. New acquisition schemes and analysis procedures require standardization ... See full document

9

Evaluation of neuroimaging biomarkers in amyotrophic lateral sclerosis

Evaluation of neuroimaging biomarkers in amyotrophic lateral sclerosis

... diagnostic challenges, relentless disease progression, marked clin- ical and genetic heterogeneity, lack of sensitive biomarkers and prognostic indicators, a long preclinical phase, and lack of effective disease ... See full document

239

Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis

Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis

... In recent years, stem cell transplantation as a new therapy for ALS patients has been extensively investigated, becoming an intense and debated field of study. In several preclinical studies using the SOD1 G93A mouse ... See full document

22

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

... However, a number of challenges remain with regard to human iPSC uses for investigation into ALS biology. Currently, the long periods of time required to generate human neural cells (for example, astrocytes) ... See full document

25

Respiratory measures in amyotrophic lateral sclerosis

Respiratory measures in amyotrophic lateral sclerosis

... Maximum voluntary ventilation (MVV), a measure of respiratory muscle endurance, requires patients to breathe as deeply and quickly as possible for 12 seconds (10) for at least two trials. Although it has been shown to be ... See full document

11

The genetics of amyotrophic lateral sclerosis: current insights

The genetics of amyotrophic lateral sclerosis: current insights

... The multiple mutations throughout the protein have also resulted in challenges determining how they are responsible for the disease phenotype. SOD1 is a ubiquitously expressed antioxidant protein, which catalyzes ... See full document

16

Palliative care for patients in the USA with amyotrophic lateral sclerosis: current challenges

Palliative care for patients in the USA with amyotrophic lateral sclerosis: current challenges

... Amyotrophic lateral sclerosis (ALS) is a progressive, neuromuscular disorder that involves the degeneration of both the upper and lower motor neurons, resulting in the eventual and complete paralysis of all ... See full document

9

Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis

Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis

... MN-like cells from hMSCs in vitro. However, this phenomenon is still controversial, particularly due to the lack of evidence of functional synapse formation between trans-differentiated MSCs. A recent in vivo study ... See full document

10

The Genetics of Amyotrophic Lateral Sclerosis: Current Insights

The Genetics of Amyotrophic Lateral Sclerosis: Current Insights

... The multiple mutations throughout the protein have also resulted in challenges determining how they are responsible for the disease phenotype. SOD1 is a ubiquitously expressed antioxidant protein, which catalyses ... See full document

48

Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis

Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis

... Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease characterized by progressive loss of motor neurons in the brainstem and spinal ... See full document

6

Amyotrophic lateral sclerosis: update and new developments

Amyotrophic lateral sclerosis: update and new developments

... Abstract: Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease. It is typically characterized by adult-onset degeneration of the upper and lower motor neurons, and is usually ... See full document

14

Current and emerging treatments for amyotrophic lateral sclerosis

Current and emerging treatments for amyotrophic lateral sclerosis

... A Medline literature search was performed to identify all studies on neuroprotective treatment of ALS published from January 1st, 1986 through August 31st, 2009, using the MeSH terms “motor neuron disease”, “motor ... See full document

19

The Environmental Epidemiology of Amyotrophic Lateral Sclerosis in Europe

The Environmental Epidemiology of Amyotrophic Lateral Sclerosis in Europe

... However a 2014 systematic review and meta-analysis of 37 studies again concluded that there was Armon class A evidence that physical activity was not a risk factor for ALS, but for occup[r] ... See full document

323

Genotype phenotype correlations of amyotrophic lateral sclerosis

Genotype phenotype correlations of amyotrophic lateral sclerosis

... Mutations in ALS2 are responsible for autosomal re- cessive, early-onset forms of upper motor neuron dis- eases, such as infantile ascending hereditary spastic paraplegia (IAHSP) and juvenile primary lateral ... See full document

10

Supportive and symptomatic management of amyotrophic lateral sclerosis

Supportive and symptomatic management of amyotrophic lateral sclerosis

... in amyotrophic lateral sclerosis including diaphragmatic pacing Sheffield Support Snood cough augmentation oropharyngeal secretion management remote monitoring of non invasive ventilation and telehealth as ... See full document

33

Gamma-synuclein pathology in amyotrophic lateral sclerosis

Gamma-synuclein pathology in amyotrophic lateral sclerosis

... Objective: The prominent histopathological feature of the amyotrophic lateral sclerosis (ALS) is the presence of intracellular inclusions in degenerating neu- rons and their axons. The appearance and ... See full document

9

Frontotemporal Cortical Thinning in Amyotrophic Lateral Sclerosis

Frontotemporal Cortical Thinning in Amyotrophic Lateral Sclerosis

... tal lateral cortex (Fig 2, area 1, orbitofrontal lateral cortex) corre- lated with disease disability (P ⫽ .04) (ALSFRS-R); CTh of the right medial frontal cortex (Fig 3, area 4, premotor cortex) corre- ... See full document

7

Programmed cell death in amyotrophic lateral sclerosis

Programmed cell death in amyotrophic lateral sclerosis

... Amyotrophic lateral sclerosis (ALS) is a relentless fatal paralytic disorder confined to the voluntary motor system (1). Its prevalence is about three to five in 100,000 individuals, making it the most ... See full document

10

Amyotrophic lateral sclerosis: update for family physicians.

Amyotrophic lateral sclerosis: update for family physicians.

... Amyotrophic lateral sclerosis is a steadily progressive disease and does not usually have abrupt exacerba- tions. Swallowing gradually becomes more difficult to the point that a gastrostomy tube might be ... See full document

7

Show all 10000 documents...